| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Acromegaly | D000172 | 6 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Middleton K et al. | Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. | 2017 | J Biomech | pmid:28552413 |
| Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
| Lu LY et al. | Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. | 2017 | J. Orthop. Res. | pmid:28248001 |
| Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
| Liu XY et al. | Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. | 2017 | Int. Immunopharmacol. | pmid:28092862 |
| Choi EM et al. | Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. | 2017 | Environ. Toxicol. | pmid:28836330 |
| Chen X et al. | Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. | 2017 | Environ. Toxicol. Pharmacol. | pmid:28738286 |
| Ozaki Y et al. | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. | 2017 | PLoS ONE | pmid:28937990 |
| Tschiderer L et al. | Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. | 2017 | PLoS ONE | pmid:28837646 |
| Åšliwicka E et al. | Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. | 2017 | PLoS ONE | pmid:28732027 |
| Bergdolt S et al. | Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. | 2017 | PLoS ONE | pmid:28614388 |
| Spirlandeli AL et al. | Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. | 2017 | Clinics (Sao Paulo) | pmid:28492723 |
| Liu J et al. | MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. | 2017 | PLoS ONE | pmid:28319142 |
| Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
| Jia J et al. | Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. | 2017 | Mol Med Rep | pmid:28260003 |
| Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
| Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
| Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
| Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
| Xiong L et al. | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. | 2017 | J. Cell Biol. | pmid:28193701 |
| Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
| Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |
| Yin LL et al. | Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. | 2017 | Eur Rev Med Pharmacol Sci | pmid:28121359 |
| Bondar C et al. | Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. | 2017 | Int J Mol Sci | pmid:28098793 |
| Shu R et al. | Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. | 2017 | PLoS ONE | pmid:28081119 |
| Ji J et al. | Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. | 2017 | J Toxicol Sci | pmid:28070108 |
| Sponder M et al. | Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. | 2017 | BMC Cardiovasc Disord | pmid:28056805 |
| Hygum K et al. | MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. | 2017 | Eur. J. Endocrinol. | pmid:28049653 |
| Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |
| Yu M et al. | Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. | 2016 Apr-Jun | J Cancer Res Ther | pmid:27461682 |
| Kwon A et al. | Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. | 2016 | Medicine (Baltimore) | pmid:27082605 |
| Hsu BG et al. | Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. | 2016 | Medicine (Baltimore) | pmid:27082570 |
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
| Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
| Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Tsuruda T et al. | Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. | 2016 | Hypertension | pmid:27001297 |
| Kats A et al. | Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. | 2016 | J. Cell. Mol. Med. | pmid:26987561 |
| Moran CS et al. | Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. | 2016 | Arterioscler. Thromb. Vasc. Biol. | pmid:26966276 |
| Zhou QL et al. | Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. | 2016 | Mol Med Rep | pmid:27357904 |
| Cong Q et al. | p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. | 2016 | Stem Cell Reports | pmid:26947973 |
| Wang C et al. | Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. | 2016 | Med. Sci. Monit. | pmid:26939934 |
| Lin J et al. | Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. | 2016 | Nat Commun | pmid:26923114 |
| D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Lu J et al. | Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. | 2016 | Exp. Biol. Med. (Maywood) | pmid:26908571 |
| Stuss M et al. | Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2016 | Endokrynol Pol | pmid:26884284 |
| Gluba-Brzózka A et al. | Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. | 2016 | Lipids Health Dis | pmid:26843213 |
| Theodoro LH et al. | Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. | 2016 | J. Periodont. Res. | pmid:26750739 |
| Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
| Bougioukli S et al. | Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. | 2016 | Bone | pmid:26723577 |
| Kobayashi Y et al. | Regulation of bone metabolism by Wnt signals. | 2016 | J. Biochem. | pmid:26711238 |
| Yuan SY et al. | Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. | 2016 | Chin J Nat Med | pmid:27114313 |
| Chen Z et al. | Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. | 2016 | Int. J. Mol. Med. | pmid:26677102 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
| Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Alam I et al. | Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. | 2016 | Endocrinology | pmid:26584014 |
| Mitchell JA et al. | Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. | 2016 | J. Bone Miner. Res. | pmid:26572781 |
| Meijome TE et al. | C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. | 2016 | J. Cell. Biochem. | pmid:26375403 |
| Zhao N et al. | Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. | 2016 | J. Bone Miner. Res. | pmid:26274352 |
| Liu YD et al. | Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. | 2016 | Osteoarthr. Cartil. | pmid:26256766 |
| Pietschmann P et al. | Immunology of Osteoporosis: A Mini-Review. | 2016 | Gerontology | pmid:26088283 |
| Liu G et al. | Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. | 2016 | Cell Tissue Res. | pmid:26004143 |
| Wang S et al. | Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. | 2016 | J Ethnopharmacol | pmid:27109342 |
| Bergamini A et al. | Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. | 2016 | Int J Med Sci | pmid:28090190 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| Chen H et al. | [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. | 2016 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:28070039 |
| Shimazaki E et al. | TGF-β and Physiological Root Resorption of Deciduous Teeth. | 2016 | Int J Mol Sci | pmid:28035998 |
| Bolamperti S et al. | Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. | 2016 | Biomed Res Int | pmid:27999816 |
| Li Y et al. | Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. | 2016 | J. Genet. | pmid:27994198 |
| Gómez-Vaquero C et al. | Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. | 2016 | PLoS ONE | pmid:27911913 |
| Ostrowska Z et al. | TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. | 2016 | Endokrynol Pol | pmid:27828689 |
| Kan C et al. | Cancer Cell Colonisation in the Bone Microenvironment. | 2016 | Int J Mol Sci | pmid:27782035 |
| Huang HM et al. | Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. | 2016 | Chin. Med. J. | pmid:27779163 |
| Kamata R et al. | EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. | 2016 | PLoS ONE | pmid:27764222 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Li M et al. | Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. | 2016 | J. Biol. Chem. | pmid:27697839 |
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |
| Ugay L et al. | Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. | 2016 | Chin. Med. J. | pmid:27411457 |
| Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
| Nagy EE et al. | High circulating osteoprotegerin levels are associated with non-zero blood groups. | 2016 | BMC Cardiovasc Disord | pmid:27387019 |
| Zhang YY et al. | Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. | 2016 | Chin J Dent Res | pmid:27379348 |
| Songia P et al. | Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. | 2016 | J. Mol. Cell. Cardiol. | pmid:27338002 |
| Li Y et al. | OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. | 2016 | Medicine (Baltimore) | pmid:27336899 |
| Dolan EB et al. | Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. | 2016 | J R Soc Interface | pmid:27335224 |
| Kassem A et al. | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | 2016 | PLoS ONE | pmid:27311019 |
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
| Li B et al. | Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. | 2016 | Int J Mol Sci | pmid:27110777 |